AYTU BIOPHARMA, INC Income Tax Expense
AYTU BIOPHARMA, INC (AYTU) reported Income Tax Expense of $21.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-09-22
- AYTU BIOPHARMA, INC income tax expense (benefit) for the quarter ending 2026-06-30 was $11.00K, a 97.48% decline year-over-year.
- AYTU BIOPHARMA, INC income tax expense (benefit) for the quarter ending 2026-03-31 was $10.00K.
- AYTU BIOPHARMA, INC income tax expense (benefit) for the quarter ending 2025-12-31 was $0.00.
- AYTU BIOPHARMA, INC income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC income tax expense (benefit) for fiscal 2026 was $21.00K, a 95.19% decline from fiscal 2025.
- AYTU BIOPHARMA, INC income tax expense (benefit) for fiscal 2025 was $437.00K, a 79.60% decline from fiscal 2024.
- AYTU BIOPHARMA, INC income tax expense (benefit) for fiscal 2024 was $2.14M.
- AYTU BIOPHARMA, INC income tax expense (benefit) for fiscal 2023 was $0.00.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $21.00K derived: sum of 2 quarters · filed 2026-09-22 | $21.00K derived: sum of 3 quarters · filed 2026-09-22 | $21.00K 10-K · filed 2026-09-22 | ||||
| 2026-03-31 | $10.00K 10-Q · filed 2026-05-13 | $10.00K derived: sum of 2 quarters · filed 2026-05-13 | $10.00K 10-Q · filed 2026-05-13 | $447.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-12-31 | $0.00 10-Q · filed 2026-02-03 | $0.00 10-Q · filed 2026-02-03 | $437.00K derived: sum of 3 quarters · filed 2026-09-22 | $315.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $437.00K derived: sum of 2 quarters · filed 2026-09-22 | $315.00K derived: sum of 3 quarters · filed 2026-09-22 | $32.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-06-30 | $437.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $315.00K derived: sum of 2 quarters · filed 2026-09-22 | $32.00K derived: sum of 3 quarters · filed 2026-09-22 | $437.00K 10-K · filed 2026-09-22 | ||||
| 2025-03-31 | -$122.00K 10-Q · filed 2026-05-13 | -$405.00K derived: sum of 2 quarters · filed 2026-05-13 | $0.00 10-Q · filed 2026-05-13 | $841.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$283.00K 10-Q · filed 2026-02-03 | $122.00K 10-Q · filed 2026-02-03 | $963.00K derived: sum of 3 quarters · filed 2026-02-03 | $1.48M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-09-30 | $405.00K 10-Q · filed 2025-11-13 | $1.25M derived: sum of 2 quarters · filed 2025-11-13 | $1.77M derived: sum of 3 quarters · filed 2025-11-13 | $2.55M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $841.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $1.36M derived: sum of 2 quarters · filed 2025-09-23 | $2.14M derived: sum of 3 quarters · filed 2025-09-23 | $2.14M 10-K · filed 2025-09-23 | $1.77M 10-K · filed 2024-09-26 | |||
| 2024-03-31 | $521.00K 10-Q · filed 2025-05-14 | $245.00K 10-Q · filed 2024-05-15 | $1.30M derived: sum of 2 quarters · filed 2025-05-14 | $1.30M 10-Q · filed 2025-05-14 | $1.07M 10-Q · filed 2024-05-15 | $1.30M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $780.00K 10-Q · filed 2025-02-12 | $828.00K 10-Q · filed 2024-02-14 | $780.00K 10-Q · filed 2025-02-12 | $828.00K 10-Q · filed 2024-02-14 | $780.00K derived: sum of 3 quarters · filed 2025-02-12 | $780.00K derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 derived: sum of 3 quarters · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $0.00 derived: sum of 2 quarters · filed 2024-09-26 | $0.00 derived: sum of 3 quarters · filed 2024-09-26 | $0.00 10-K · filed 2024-09-26 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 10-Q · filed 2024-05-15 | |||||
| 2022-12-31 | $0.00 10-Q · filed 2024-02-14 | $0.00 10-Q · filed 2024-02-14 | ||||||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $0.00 derived: sum of 2 quarters · filed 2023-10-12 | -$3.00K derived: sum of 3 quarters · filed 2023-10-12 | -$110.00K 10-K · filed 2023-10-12 | ||||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -$3.00K derived: sum of 2 quarters · filed 2023-05-11 | -$110.00K 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | -$3.00K 10-Q · filed 2023-02-21 | -$110.00K 10-Q · filed 2023-02-21 | ||||||
| 2021-09-30 | -$107.00K 10-Q/A · filed 2023-02-21 | |||||||
| 2021-06-30 | $259.00K 10-K · filed 2022-09-27 | |||||||
| 2020-12-31 | $0.00 10-Q · filed 2022-02-14 | $0.00 10-Q · filed 2022-02-14 | ||||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | $0.00 10-K · filed 2021-09-28 | |||||||
| 2019-06-30 | $0.00 10-K · filed 2020-10-06 | |||||||
| 2018-06-30 | $0.00 10-K · filed 2019-09-26 | |||||||
| 2017-12-31 | $6.60M 10-Q · filed 2018-05-14 | |||||||
| 2017-06-30 | $0.00 10-K · filed 2017-08-31 | |||||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $0.00 derived: sum of 2 quarters · filed 2017-08-31 | $0.00 derived: sum of 3 quarters · filed 2017-08-31 | $0.00 10-K · filed 2017-08-31 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-11 | $0.00 derived: sum of 2 quarters · filed 2016-05-11 | $0.00 10-Q · filed 2016-05-11 | $0.00 derived: sum of 4 quarters · filed 2016-09-01 | ||||
| 2015-12-31 | $0.00 10-Q · filed 2016-02-11 | $0.00 10-Q · filed 2016-02-11 | $0.00 derived: sum of 3 quarters · filed 2016-09-01 | $0.00 derived: sum of 4 quarters · filed 2016-09-01 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2016-09-01 | $0.00 derived: sum of 3 quarters · filed 2016-09-01 | $0.00 derived: sum of 4 quarters · filed 2016-09-01 | ||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $0.00 derived: sum of 2 quarters · filed 2016-09-01 | $0.00 derived: sum of 3 quarters · filed 2016-09-01 | -$23.91K 10-K · filed 2016-09-01 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-11 | $0.00 derived: sum of 2 quarters · filed 2016-05-11 | -$23.91K 10-Q · filed 2016-05-11 | -$288.45K derived: sum of 4 quarters · filed 2016-05-11 | ||||
| 2014-12-31 | $0.00 10-Q · filed 2016-02-11 | -$23.91K 10-Q · filed 2016-02-11 | -$288.45K derived: sum of 3 quarters · filed 2016-02-11 | -$611.02K derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-09-30 | -$23.91K 10-Q · filed 2015-11-06 | -$288.45K derived: sum of 2 quarters · filed 2015-11-06 | -$611.02K derived: sum of 3 quarters · filed 2015-11-06 | |||||
| 2014-06-30 | -$264.54K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | -$587.11K derived: sum of 2 quarters · filed 2015-09-28 | -$813.70K 10-K · filed 2015-09-28 | |||||
| 2014-03-31 | -$322.57K 10-Q · filed 2015-05-19 | -$549.16K 10-Q · filed 2015-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |